According to a filing with US Securities Exchange Commission, the drug maker said as of March 31, 2013, DRL had 21 active products in the proprietary products pipeline, of which six are in clinical development stage.
CNBC-TV18's Storyboard catches STAR India in the throes of its biggest initiative after KBC, ranks IPL teams on their brand value and finds out how IIM grads are making it big on the lit circuit